1 Leuppi JD, Steurer-Stey C, Peter M, et al. Asthma control in Switzerland: a general practitioner based survey. Curr Med Res Opin. 2006;22:2159–66.
2 Teach SJ, Gill MA, Togias A et al. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol. 2015;136:1476–85.
3 Brusselle GG, Maes T, Bracke KR. Eosinophils in the spotlight: Eosinophilic airway inflammation in non-allergic asthma. Nat Med. 2013;19:977–9.
4 Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178:218–24.
5 www.ginasthma.org.
6 Al Samri MR, Benedetti A, Préfontaine D et al. Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: a prospective study using multiple samples. J Allergy Clin Immunol. 2010;125;1161–3.
7 Sidele O, Suratt BT, Black KE et al. Obesity and asthma: an inflammatory disease of adipose tissue not the air-way.
Am J Respir Crit Care Med. 2012;186:598–605.
8 Carpio C, Villasante C, Galera R et al. Systemic inflammation and higher perception of dyspnoea mimicking asthma in obese subjects. J Allergy Clin Immunol. 2016;137:718–26.
9 Dixon AE, Pratley RE, Forgione PM et al. Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. J Allergy Clin Immunol. 2011;128:508–15.
10 Sin DD, Miravitlles M, Mannino DM et al. What is asthma−COPD overlap syndrome? Towards a consensus definition from a round table discussion.European Respiratory Journal. 2016;48:664–73.
11 Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. ERJ. 2003;22:268–73.
12 Rackemann FM. A working classification of asthma. Am J Med. 1947;3:601–6.
13 Wüthrich 8, Schmid-Grendelmeier P, Schindler C, et al. Prevalence of atopy and respiratory allergic diseases in the elderly SAPALDIA population. Int Arch Allergy Immunol. 2013;162:143–8.
14 Rothe T. Allergenkarenz als diagnostisches Instrument. Allergologie. 2010;33:441–4.
15 www.asthmacontroltest.com.
16 Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The GOAL Study. Am J Respir Crit Care Med. 2004;170:836–44.
17 Rothe T, Leuppi J et les membres du «Groupe de travail Asthme» de la Société Suisse de Pneumologie. Symptômes asthmatiques réfractaires au traitement. Forum Méd Suisse. 2015;15(24):573–9.
18 Chalmers GW, Macleod KJ, Little SA, et al. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax. 2002;57:226–30.
19 Bel EH; Wenzel SE, Thompson PF et al. Oral glucocorticoid sparing effect of mepolizumab in eosinophilic asthma. N Engl J Med. 2014;371:1189–97.
20 Dahlén B et al. The leukotrienereceptor antagonist Montelukast blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics. Eur Respir J. 1993;6:1018.
21 Stelmach R, do Patrocinio T, Nunes M et al. Effect of treating allergic rhinitis with corticosteroids in patients with mild-to-moderate persistent asthma. Chest. 2005;128:3140–7.
22 Platts-Mills TA. Allergen avoidance in the treatment of asthma: problems with the meta-analyses. J Allergy Clin Immunol. 2008;122:694–6.
23 Rothe T, Hoyler K. Respiratorische Allergien in der Praxis. PRAXIS. 2016;105:891–97.
24 Pfaar O, Bachert C, Bufe A et al. Leitlinie zur (allergen-) spezifischen Immuntherapie bei IgE-vermittelten allergischen Erkrankungen. Allergo J Int. 2014;23:282.
25 Virchow JC, Backer V, Kuna P et al. Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: A randomized clinical trial. JAMA. 2016;315:1715–25.
26 Oborne J, Mortimer K, Hubbard RB et al. Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations:
a randomized, double-blind, placebo-controlled, parallel-group clinical trial. Am J Respir Crit Care Med. 2009;180:598–602.
27 Rabe KF, Atienza T, Magyar P et al. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet. 2006;368:744–53.